欧洲血液辐照市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型（静脉激光血液辐照、经皮激光血液辐照和体外血液辐照）、适应症（急性白血病、淋巴瘤、实体瘤、盆腔）肿瘤等）和最终用户（医院、血库、诊断诊所和研究机构）
No. of Pages: 109 | Report Code: BMIRE00027192 | Category: Life Sciences
No. of Pages: 109 | Report Code: BMIRE00027192 | Category: Life Sciences
欧洲血液辐照市场预计将从 2022 年的 2690 万美元增长到 2028 年的 4024 万美元。预计 2022 年至 2028 年复合年增长率为 6.9% .
医疗保健支出的增加和政府举措提振欧洲血液辐照市场
传染性和非传染性疾病的治疗格局随着时间和技术、医疗保健支出的增加以及大量人口意识的提高而不断发展。 X 射线和伽马射线照射器广泛用于血液照射，以确保患者安全并防止进一步的并发症。血液照射有助于控制血液恶性肿瘤并预防输血相关的移植物抗宿主 (TGVH) 疾病。 FDA 已批准使用血液辐照器，并实施更严格的安全措施，以降低未经授权使用放射性材料的风险。英国政府的输血严重危害 (SHOT) 计划通过分析从参与输血和血液成分输注的医疗机构收集的匿名信息来支持患者安全，这些信息涉及输血程序后参与血液和血液成分输注的医疗机构报告的不良事件和反应。此外，欧洲血液联盟 (EBA)、罗多彼自愿献血组织以及来自欧洲国家的其他各种政府和非政府组织/项目正在提高人们的献血意识，以满足日益增长的血液需求。因此，此类鼓励献血的政府和非政府举措正在推动血液辐照市场的增长。
市场概览< /strong>
欧洲是血液照射的第二大市场，该地区的市场增长归因于以下因素癌症、心脏病、糖尿病和各种其他非传染性慢性病的患病率不断上升。此外，用于研究和开发的资金不断增加。开发活动可能会在未来几年为市场参与者提供机会。此外，德国的制药业在中小企业中占据第四位。就治疗而言，未来几年该国可能仍然是欧洲医疗保健行业最具吸引力的目的地之一。该行业的增长受到多种因素的推动，例如研发投资的增加以及医院、血库和诊所等先进医疗设施。德国血液辐照市场主要受到国家人口老龄化、社会政治环境和人均医疗保健支出较高的推动。
欧洲血液放射市场细分
< p>欧洲血液辐照市场分为类型、适应症、最终用户和国家。
日立有限公司；最佳Theratronics有限公司；吉拉多尼公司；伽玛服务医疗有限公司；类型医疗；和 Actemium 是该地区血液辐照市场的领先公司。
Strategic insights for Europe Blood Irradiation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 26.90 Million |
| Market Size by 2028 | US$ 40.24 Million |
| Global CAGR (2022 - 2028) | 6.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Blood Irradiation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Blood Irradiation Market is valued at US$ 26.90 Million in 2022, it is projected to reach US$ 40.24 Million by 2028.
As per our report Europe Blood Irradiation Market, the market size is valued at US$ 26.90 Million in 2022, projecting it to reach US$ 40.24 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Blood Irradiation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Blood Irradiation Market report:
The Europe Blood Irradiation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Blood Irradiation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Blood Irradiation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Blood Irradiation Market
